According to a recent LinkedIn post from Neuromod Devices Ltd, the company plans to participate in the American Academy of Audiology Expo 2026 in San Antonio, Texas, scheduled for April 22–25. The post indicates Neuromod intends to engage with the audiology community and showcase its Lenire device as part of broader discussions on advancing tinnitus care.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post suggests an emphasis on positioning Lenire as an innovative, evidence-based solution in tinnitus treatment, targeting both audiologists and ENT professionals. For investors, visible presence at a major specialty conference may support clinician awareness, potential adoption, and longer-term revenue opportunities in tinnitus therapy, while also signaling Neuromod’s ongoing focus on professional-channel growth and market education.